NACF Conference Could Create Catalyst for Vertex (VRTX) - Analyst
Go back to NACF Conference Could Create Catalyst for Vertex (VRTX) - Analyst| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 63.83 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $63.83 | 52 Week High | $77.12 | |||
| Open | $63.83 | 52 Week Low | $49.03 | |||
| Day High | $63.83 | P/E | 41.45 | |||
| Day Low | $63.83 | EPS | $1.54 | |||
| Volume | 972 | |||||
| Gilead Sciences (NASDAQ: GILD) | Delayed: 138.36 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $138.36 | 52 Week High | $108.63 | |||
| Open | $138.36 | 52 Week Low | $71.39 | |||
| Day High | $138.36 | P/E | 76.44 | |||
| Day Low | $138.36 | EPS | $1.81 | |||
| Volume | 2,198 | |||||
| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 505.75 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $505.75 | 52 Week High | $134.71 | |||
| Open | $505.75 | 52 Week Low | $73.31 | |||
| Day High | $505.75 | P/E | N/A | |||
| Day Low | $505.75 | EPS | $-1.98 | |||
| Volume | 400 | |||||
